In both prostate and breast cancer, TGF-β was found to stimulate tumor microenvironment by modulating the recruitment of bone marrow-derived mesenchymal stem cells (BMSCs) into the tumor, mediated by transmembrane protein neural cadherin (N-cadherin) [116,117]. This evidence concerns the gene CDH2 and breast cancer.